An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, according to a poster presented here. This molecular characterization may ...
An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is ...
A new study offers hope in the fight against flesh-eating fungus infections. Researchers have discovered a promising antibody ...
Tharimmune, Inc. (Nasdaq:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company focused on immunology and inflammation, today announced positive preclinical results for its ...
On , US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical-an innovative biopharmaceutical company incubated by Beijing Hotgen Biotech Co., ...
What is Celiac disease? Celiac disease is caused when a person’s immune system reacts abnormally to a protein called gluten.
Learn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.
BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today published a presentation including a simulation[1] of potential future sales for ...
The author of the ‘Leonard List’ that highlights emerging hematologic research to be presented at annual ASH meetings is also ...
Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...